ALDER BIOPHARMACEUTICALS Trademark

Trademark Overview

On Friday, April 5, 2019, a trademark application was filed for ALDER BIOPHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the ALDER BIOPHARMACEUTICALS trademark a serial number of 88373931. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 7, 2022. This trademark is owned by Alder BioPharmaceuticals, Inc.. The ALDER BIOPHARMACEUTICALS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations used for the prevention, management and treatment of headaches, migraines, pain, immune and inflammatory disorders and diseases, and neurological disorders and conditions
alder biopharmaceuticals

General Information

Serial Number88373931
Word MarkALDER BIOPHARMACEUTICALS
Filing DateFriday, April 5, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 7, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 6, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations used for the prevention, management and treatment of headaches, migraines, pain, immune and inflammatory disorders and diseases, and neurological disorders and conditions
Disclaimer with Predetermined Text"BIOPHARMACEUTICALS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 25, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLUNDBECK SEATTLE BIOPHARMACEUTICALS, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressBOTHELL, WA 98011
Party NameAlder BioPharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBothell, WA 98011
Party NameAlder BioPharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBothell, WA 98011

Trademark Events

Event DateEvent Description
Monday, November 7, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 7, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, February 22, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, February 19, 2022SOU EXTENSION 5 GRANTED
Thursday, February 10, 2022SOU EXTENSION 5 FILED
Thursday, February 17, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, February 10, 2022TEAS EXTENSION RECEIVED
Wednesday, August 25, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 23, 2021SOU EXTENSION 4 GRANTED
Monday, August 23, 2021SOU EXTENSION 4 FILED
Monday, August 23, 2021TEAS EXTENSION RECEIVED
Friday, March 19, 2021ASSIGNED TO EXAMINER
Tuesday, February 23, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 19, 2021SOU EXTENSION 3 GRANTED
Friday, February 19, 2021SOU EXTENSION 3 FILED
Friday, February 19, 2021TEAS EXTENSION RECEIVED
Friday, September 4, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 2, 2020SOU EXTENSION 2 GRANTED
Wednesday, September 2, 2020SOU EXTENSION 2 FILED
Wednesday, September 2, 2020TEAS EXTENSION RECEIVED
Wednesday, March 4, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 2, 2020SOU EXTENSION 1 GRANTED
Monday, March 2, 2020SOU EXTENSION 1 FILED
Monday, March 2, 2020TEAS EXTENSION RECEIVED
Wednesday, December 11, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, October 1, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 6, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 6, 2019PUBLISHED FOR OPPOSITION
Wednesday, July 17, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, July 1, 2019ASSIGNED TO LIE
Thursday, June 20, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 20, 2019EXAMINER'S AMENDMENT ENTERED
Thursday, June 20, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, June 20, 2019EXAMINERS AMENDMENT E-MAILED
Thursday, June 20, 2019EXAMINERS AMENDMENT -WRITTEN
Monday, June 17, 2019ASSIGNED TO EXAMINER
Thursday, April 25, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, April 9, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

biopharmaceuticals alder disorders inflammatory immune diseases conditions neurological pain migraines used preparations